Zuhat Urakçı - Concepedia

Author

Zuhat Urakçı

Also Known As

Daniel Dietrich, Z Urakci, Z Urakçı, Z. Urakci, Z. Urakcı, Z. Urakçı, Zuhad Urakçı, Zuhat URAKCI, Zuhat URAKÇI, Zuhat UrakcI

156

Publications

700

Citations

H-Index

Concepts

All Affiliations

Dicle University Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi Selçuk University Dokuz Eylül University Gazi University

About

Zuhat Urakçı is an author at Dicle University specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	148
2	Pathology	2	2	82
3	Surgical Oncology	2	2	28
4	Health Sciences	1	1	38
5	Diabetes	1	1	64

Zuhat Urakçı

Publications

440

Citations

H-Index

Page 1

	Year	Citations
Type 2 diabetes mellitus and prognosis in early stage breast cancer women Zafer Pekkolay, Mehmet Küçüköner, Ali̇ İnal, Medical Oncology Breast OncologyMedicineDiabetesPathologyBreast Cancer	2011	64
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, Breast Cancer Breast OncologyCapecitabine Combination TherapyMedicineBrain MetastasisClinical Outcomes	2013	38
Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer? Ali̇ İnal, Mehmet Küçüköner, Zuhat Urakçı, Revista Portuguesa de Pneumologia	2013	33
Oral Etoposide for Platinum-Resistant and Recurrent Epithelial Ovarian Cancer: a Study by the Anatolian Society of Medical Oncology Mehmet Küçüköner, Abdurrahman Işıkdoğan, Şebnem Yaman, Asian Pacific Journal of Cancer Prevention	2012	29
Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology) Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, Oncology	2012	25
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study Nadiye Akdeniz, Doğan Uncu, Mevlüde İnanç, International Journal of Colorectal Disease	2021	23
Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab Hamza Ertuğrul, Mehmet Küçüköner, Ali̇ İnal, Breast Cancer Breast OncologyBrain MetastasesMedicinePathologyBreast Cancer	2014	18
The role of basal 18F-FDG PET/CT maximum standard uptake value and maximum standard uptake change in predicting pathological response in breast cancer patients receiving neoadjuvant chemotherapy Nadiye Akdeniz, Halil Kömek, Mehmet Küçüköner, Nuclear Medicine Communications	2020	17
The Role of Acoustic Radiation Force Impulse Elastography in the Differentiation of Infectious and Neoplastic Liver Lesions Cemil Göya, Cihad Hamidi, Alpaslan Yavuz, Ultrasonic Imaging	2015	16
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, International Journal of Clinical Oncology Prognostic FactorsUrologySurgical OncologyMetastatic Urothelial CarcinomaGenitourinary Cancer	2021	16

Page 1